|
|
Volumn 290, Issue 5494, 2000, Pages 1063-
|
|
Company, researchers battle over data access
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
BUDGET;
DATA ANALYSIS;
DRUG EFFECT;
DRUG RESEARCH;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LAW SUIT;
NOTE;
PRIORITY JOURNAL;
ARTICLE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DISEASE COURSE;
DRUG INDUSTRY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
IMMUNOLOGY;
INTERPERSONAL COMMUNICATION;
PUBLISHING;
RANDOMIZED CONTROLLED TRIAL;
STATISTICAL ANALYSIS;
UNITED STATES;
UNIVERSITY;
VIROLOGY;
VIRUS LOAD;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
AIDS VACCINES;
CALIFORNIA;
DATA INTERPRETATION, STATISTICAL;
DISEASE PROGRESSION;
DRUG INDUSTRY;
HIV;
HIV INFECTIONS;
HUMANS;
NEGOTIATING;
PUBLISHING;
RANDOMIZED CONTROLLED TRIALS;
UNIVERSITIES;
VIRAL LOAD;
|
|
EID: 0034634225
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.290.5494.1063 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|